HIV was not created in a laboratory. It evolved naturally from a closely related virus found in chimpanzees in central Africa, jumping into humans through contact with infected animal blood, most likely during hunting. The strain responsible for the global pandemic, HIV-1 Group M, entered the human population around the 1930s based on genetic dating analysis. A second, less widespread type called HIV-2 came from a different primate species in West Africa.
How HIV Jumped From Animals to Humans
Before HIV existed in people, a family of viruses called simian immunodeficiency viruses (SIV) had been circulating in African primates for thousands of years. Chimpanzees themselves originally picked up SIV by hunting and eating smaller monkeys, a well-documented behavior. Over time, these viruses adapted to their chimpanzee hosts.
The specific chimpanzee subspecies responsible for giving rise to HIV-1 is the central chimpanzee (Pan troglodytes troglodytes), found in parts of Cameroon, Gabon, and the Republic of the Congo. All four known groups of HIV-1, labeled M, N, O, and P, trace back to SIV strains from this one subspecies. Each group represents a separate animal-to-human transmission event, meaning the virus crossed into humans not once but at least four independent times.
The most accepted explanation for how these crossover events happened is bushmeat hunting. When hunters killed or butchered chimpanzees, they were exposed to infected blood through cuts or open wounds on their skin. This kind of direct blood contact carries the highest risk for transmitting blood-borne viruses. The virus didn’t need to be ingested. A single exposure through broken skin or a mucous membrane was enough for SIV to enter a human host, where it gradually adapted into what we now call HIV.
HIV-1 vs. HIV-2: Two Separate Origins
HIV-1 and HIV-2 are distinct viruses with different animal sources. HIV-1, the type responsible for the vast majority of infections worldwide (over 70 million people to date), came from central African chimpanzees. HIV-2 came from sooty mangabeys, a smaller monkey species native to West Africa. Each of the multiple groups within HIV-2 also represents its own independent cross-species jump.
HIV-2 is far less common, with fewer than 2 million people infected, mostly in West Africa and countries with historical colonial ties to that region. It also progresses more slowly and is less easily transmitted than HIV-1. The geographic concentration of HIV-2 in West Africa matches the natural habitat of sooty mangabeys, reinforcing the link between local bushmeat practices and the emergence of the virus.
When the Virus First Appeared in Humans
Molecular clock analysis, a technique that estimates how long ago two related viruses diverged based on their rate of genetic mutation, places the origin of HIV-1 Group M in the 1930s. This means the virus was quietly spreading in human populations for roughly 50 years before AIDS was first recognized as a new disease in 1981. The oldest confirmed HIV-positive human blood sample dates to 1959, collected in what is now Kinshasa in the Democratic Republic of the Congo.
The long gap between the initial crossover and the recognition of AIDS explains why the origin was so difficult to trace. By the time doctors in the United States noticed clusters of unusual infections in 1981, the virus had already diversified into multiple subtypes across central Africa.
How the Virus Copies Itself Inside the Body
Once HIV enters a person, it targets a specific type of immune cell called a CD4 cell, one of the body’s key defenders against infection. The virus attaches to the surface of a CD4 cell and fuses with it, releasing its genetic material inside. HIV carries its genes as RNA, but human cells read DNA. So the virus uses a specialized enzyme called reverse transcriptase to convert its RNA into DNA, which can then slip into the cell’s nucleus and merge with the cell’s own genetic code.
At that point, the infected cell essentially becomes a virus factory. Every time the cell activates to do its normal immune job, it also reads the viral instructions and produces new viral proteins and RNA copies. These components gather at the cell’s surface and bud off as new virus particles.
These freshly released particles aren’t immediately infectious. They need one more step: a viral enzyme called protease cuts long chains of protein into the smaller, functional pieces the virus needs to form a stable core. This cutting process, called maturation, happens rapidly, within less than a minute of the particle leaving the cell. Without it, the virus particle can’t infect a new cell. This is why protease inhibitors, a major class of HIV medication, are so effective. They block this final assembly step, leaving the virus unable to mature into a functional form.
Why HIV Is Not Man-Made
The idea that HIV was engineered in a laboratory has persisted since the early days of the epidemic, but the genetic evidence overwhelmingly contradicts it. The virus’s family tree is traceable through a clear chain of primate viruses. SIV strains from central chimpanzees are the closest genetic relatives of HIV-1, and SIV from sooty mangabeys is the closest match for HIV-2. These relationships follow the same branching pattern scientists see in other viruses that have jumped between species naturally.
The fact that HIV crossed into humans at least four separate times for HIV-1, and multiple additional times for HIV-2, further supports a natural origin. A lab-created virus would show a single point of introduction. Instead, each HIV group has a distinct and traceable SIV ancestor from the expected primate host in the expected geographic region. The genetic diversity among HIV groups mirrors the diversity of SIV strains found in wild primate populations, a pattern that would be essentially impossible to fabricate. The scientific consensus, built on decades of field sampling, genetic sequencing, and evolutionary analysis, is that HIV arose through repeated natural cross-species transmission driven by human contact with infected primates.